About 15 results found for searched term "ROCK" (0.052 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M7388 | TC-S 7001 | ROCK |
| ROCK inhibitor; TC-S 7001 | ||
| TC-S 7001 is a potent and highly selective ROCK inhibitor; orally active. | ||
| M11024 | ROCK2-IN-2 | ROCK |
| Rock2-in-2 is a selective ROCK2 inhibitor with IC50 <1 μM. | ||
| M13731 | ROCK inhibitor-2 | ROCK |
| ROCK inhibitor-2 is a selective dual ROCK1 and ROCK2 inhibitor with IC50s of 17 nM and 2 nM, respectively. | ||
| M41590 | ROCK2-IN-6 hydrochloride | ROCK |
| ROCK2-IN-6 hydrochloride is a selective ROCK2 inhibitor, can be used for ROCK mediated diseases, autoimmune diseases and inflammation research. | ||
| M41591 | ROCK2-IN-6 | ROCK |
| ROCK2-IN-6 is a selective ROCK2 inhibitor, can be used for ROCK mediated diseases, autoimmune diseases and inflammation research. | ||
| M41595 | ROCK-IN-8 | ROCK |
| ROCK-IN-8 is a ROCK inhibitor, with an IC50 value less than 100 nM. | ||
| M41596 | ROCK-IN-7 | ROCK |
| ROCK-IN-7 is a ROCK kinase inhibitor. | ||
| M41597 | ROCK-IN-9 | ROCK |
| ROCK-IN-9 is a ROCK inhibitor. | ||
| M49538 | ROCK2-IN-5 | ROCK |
| ROCK2-IN-5 is a hybrid compound containing structural fragments of the Rho kinase inhibitor fasudil and the NRF2 inducers caffeic and ferulic acids. | ||
| M49539 | ROCK2-IN-7 | ROCK |
| ROCK2-IN-7 is a kinase inhibitor targeting to ROCK2. | ||
| M49540 | ROCK-IN-1 | ROCK |
| ROCK-IN-1 is a potent inhibitor of ROCK, with an IC50 of 1.2 nM for ROCK2. | ||
| M49541 | ROCK-IN-32 | ROCK |
| ROCK-IN-32 is a ROCK inhibitor, with an IC50 value of 11 nM for ROCK2. | ||
| M49542 | ROCK-IN-4 | ROCK |
| ROCK-IN-4 is a potent ROCK inhibitor maintaining NO releasing ability. | ||
| M49543 | ROCK-IN-6 | ROCK |
| ROCK-IN-6 is a potent and selectiveROCK2 inhibitor with an IC50 of 2.19 nM. | ||
| M49772 | Akt/ROCK-IN-1 | ROCK |
| Akt/ROCK-IN-1 (B12) is a dual inhibitor for Akt and ROCK, with the IC50s of 0.023 nM and 1.47 nM, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
